Medibank Private
Medibank Private Limited, an integrated healthcare company, provides private health insurance and health solutions in Australia. The last earnings update was 152 days ago. More info.
Add to Portfolio Compare Print
- Medibank Private has significant price volatility in the past 3 months.
MPL Share Price and Events
7 Day Returns
1 Year Returns
MPL Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Medibank Private (MPL) | -1.6% | 5.9% | 32.1% | 17% | 19.3% | - |
| AU Insurance | -0.6% | 2.6% | 6.2% | 4.9% | 20.1% | 16.5% |
| AU Market | -0.1% | 1.7% | 5.8% | 4.9% | 19.7% | 12.1% |
1 Year Return vs Industry and Market
- MPL outperformed the Insurance industry which returned 4.9% over the past year.
- MPL outperformed the Market in Australia which returned 4.9% over the past year.
MPL Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Medibank Private
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Medibank Private.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | Excess Returns Model | |
| Stable EPS |
Weighted future Return on Equity estimates from 6 analysts.
= Stable Book Value * Return on Equity = A$0.74 * 21.7% |
A$0.16 |
| Book Value of Equity per Share | Weighted future Book Value estimates from 6 analysts. | A$0.74 |
| Discount Rate (Cost of Equity) | See below | 7.1% |
| Perpetual Growth Rate | 10-Year AU Government Bond Rate | 2.3% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year AU Govt Bond Rate | 2.3% |
| Equity Risk Premium | S&P Global | 6% |
| Insurance Unlevered Beta | Simply Wall St/ S&P Global | 0.69 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.685 (1 + (1- 30%) (0%)) |
0.789 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
0.8 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.31% + (0.8 * 5.96%) |
7.08% |
Discounted Cash Flow Calculation for ASX:MPL using Excess Returns Model Model
The calculations below outline how an intrinsic value for Medibank Private is arrived at using the Excess Return Model. This approach is used for finance firms where free cash flow is difficult to estimate.
In the Excess Return Model the value of a firm can be written as the sum of capital invested currently in the firm and the present value of excess returns that the firm expects to make in the future.
The model is sensitive to the Return on Equity of the company versus the Cost of Equity, how these are calculated is detailed below the main calculation.
Note the calculations below are per share.
See our documentation to learn about this calculation.
| Calculation | Result | |
|---|---|---|
| Excess Returns |
= (Stable Return on equity – Cost of equity) (Book Value of
Equity per share)
= (21.7% – 7.08%) * A$0.74) |
A$0.11 |
| Terminal Value of Excess Returns |
= Excess Returns / (Cost of Equity -
Expected Growth Rate)
= A$0.11 / (7.08% - 2.31%) |
A$2.25 |
| Value of Equity |
= Book Value per share + Terminal Value of
Excess Returns
= A$0.74 + A$2.25 |
A$2.99 |
| Calculation | Result | |
|---|---|---|
| Value per share (AUD) | From above. | A$2.99 |
| Current discount | Discount to share price of
A$3.58
= -1 x (A$3.58 - A$2.99) / A$2.99 |
-19.8% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
- The current share price of Medibank Private is above its future cash flow value.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Medibank Private's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Medibank Private's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-31) in AUD | A$0.15 |
| ASX:MPL Share Price ** | ASX (2019-07-15) in AUD | A$3.58 |
| Australia Insurance Industry PE Ratio | Median Figure of 10 Publicly-Listed Insurance Companies | 22.12x |
| Australia Market PE Ratio | Median Figure of 546 Publicly-Listed Companies | 16.25x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Medibank Private.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = ASX:MPL Share Price ÷ EPS (both in AUD) = 3.58 ÷ 0.15 |
24.26x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Medibank Private is overvalued based on earnings compared to the AU Insurance industry average.
- Medibank Private is overvalued based on earnings compared to the Australia market.
Price based on expected Growth
Does
Medibank Private's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 24.26x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 10 Analysts |
-1.9%per year |
| Australia Insurance Industry PEG Ratio | Median Figure of 9 Publicly-Listed Insurance Companies | 1.67x |
| Australia Market PEG Ratio | Median Figure of 361 Publicly-Listed Companies | 1.37x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 24.26x ÷ -1.9% |
-12.51x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Medibank Private earnings are not expected to grow next year, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
Medibank Private's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-31) in AUD | A$0.66 |
| ASX:MPL Share Price * | ASX (2019-07-15) in AUD | A$3.58 |
| Australia Insurance Industry PB Ratio | Median Figure of 10 Publicly-Listed Insurance Companies | 3.05x |
| Australia Market PB Ratio | Median Figure of 1,693 Publicly-Listed Companies | 1.7x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = ASX:MPL Share Price ÷ Book Value per Share (both in AUD) = 3.58 ÷ 0.66 |
5.39x |
* Primary Listing of Medibank Private.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Medibank Private is overvalued based on assets compared to the AU Insurance industry average.
Value checks
We assess Medibank Private's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Insurance industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Insurance industry average (and greater than 0)? (1 check) Medibank Private has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
MPL Future Performance
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Medibank Private's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 2.3%.
Growth vs Market Checks
- Medibank Private's earnings are expected to decrease over the next 1-3 years, this is below the Australia market average.
- Medibank Private's revenue growth is positive but not above the Australia market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| ASX:MPL Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 10 Analysts | -1.9% |
| ASX:MPL Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 10 Analysts | 1.4% |
| Australia Insurance Industry Earnings Growth Rate | Market Cap Weighted Average | 13.8% |
| Australia Insurance Industry Revenue Growth Rate | Market Cap Weighted Average | 0.1% |
| Australia Market Earnings Growth Rate | Market Cap Weighted Average | 7.3% |
| Australia Market Revenue Growth Rate | Market Cap Weighted Average | 3.3% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (6 months ago) | See Below |
| Future Estimates | Average of up to 10 Analyst Estimates (S&P Global) | See Below |
| Date (Data in AUD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-06-30 | 7,712 | 1 | ||
| 2022-06-30 | 7,440 | 1 | ||
| 2021-06-30 | 7,167 | 675 | 408 | 5 |
| 2020-06-30 | 6,953 | 627 | 444 | 5 |
| 2019-06-30 | 7,163 | 392 | 442 | 5 |
| Date (Data in AUD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-31 | 7,049 | 377 | 407 |
| 2018-09-30 | 7,032 | 393 | 426 |
| 2018-06-30 | 7,015 | 408 | 445 |
| 2018-03-31 | 7,010 | 428 | 454 |
| 2017-12-31 | 7,006 | 448 | 463 |
| 2017-09-30 | 6,977 | 421 | 456 |
| 2017-06-30 | 6,948 | 393 | 450 |
| 2017-03-31 | 6,914 | 379 | 436 |
| 2016-12-31 | 6,879 | 365 | 422 |
| 2016-09-30 | 6,843 | 359 | 420 |
| 2016-06-30 | 6,807 | 352 | 418 |
| 2016-03-31 | 6,791 | 363 | 393 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (6 months ago) | See Below |
| Future Estimates | Average of up to 10 Analyst Estimates (S&P Global) | See Below |
All data from Medibank Private Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in AUD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-06-30 | ||||
| 2022-06-30 | ||||
| 2021-06-30 | 0.15 | 0.17 | 0.14 | 3.00 |
| 2020-06-30 | 0.16 | 0.17 | 0.15 | 5.00 |
| 2019-06-30 | 0.16 | 0.17 | 0.16 | 5.00 |
| Date (Data in AUD Millions) | EPS * |
|---|---|
| 2018-12-31 | 0.15 |
| 2018-09-30 | 0.15 |
| 2018-06-30 | 0.16 |
| 2018-03-31 | 0.16 |
| 2017-12-31 | 0.17 |
| 2017-09-30 | 0.17 |
| 2017-06-30 | 0.16 |
| 2017-03-31 | 0.16 |
| 2016-12-31 | 0.15 |
| 2016-09-30 | 0.15 |
| 2016-06-30 | 0.15 |
| 2016-03-31 | 0.14 |
*GAAP earnings excluding extraordinary items.
Future performance checks
We assess Medibank Private's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Australia market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Australia market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Medibank Private has a total score of 1/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
MPL Past Performance
How has Medibank Private performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Medibank Private's year on year earnings growth rate has been positive over the past 5 years.
- Medibank Private's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Medibank Private's 1-year earnings growth is negative, it can't be compared to the AU Insurance industry average.
Earnings and Revenue History
All data from Medibank Private Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in AUD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-31 | 7,048.50 | 407.20 | 1,122.30 | |
| 2018-09-30 | 7,031.50 | 426.15 | 1,108.00 | |
| 2018-06-30 | 7,014.50 | 445.10 | 1,093.70 | |
| 2018-03-31 | 7,010.15 | 454.15 | 1,082.00 | |
| 2017-12-31 | 7,005.80 | 463.20 | 1,070.30 | |
| 2017-09-30 | 6,976.95 | 456.35 | 1,071.50 | |
| 2017-06-30 | 6,948.10 | 449.50 | 1,072.70 | |
| 2017-03-31 | 6,913.70 | 435.70 | 1,059.60 | |
| 2016-12-31 | 6,879.30 | 421.90 | 1,046.50 | |
| 2016-09-30 | 6,843.35 | 419.75 | 1,050.70 | |
| 2016-06-30 | 6,807.40 | 417.60 | 1,054.90 | |
| 2016-03-31 | 6,790.60 | 393.35 | 1,074.95 | |
| 2015-12-31 | 6,773.80 | 369.10 | 1,095.00 | |
| 2015-09-30 | 6,727.70 | 327.20 | 1,101.75 | |
| 2015-06-30 | 6,681.60 | 285.30 | 1,108.50 | |
| 2015-03-31 | 6,631.30 | 244.45 | 1,151.60 | |
| 2014-12-31 | 6,581.00 | 203.60 | 1,194.70 | |
| 2014-09-30 | 6,533.35 | 167.20 | 1,216.80 | |
| 2014-06-30 | 6,485.70 | 130.80 | 1,238.90 | |
| 2013-06-30 | 6,005.00 | 232.70 | 1,023.20 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Medibank Private has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
- Medibank Private used its assets more efficiently than the AU Insurance industry average last year based on Return on Assets.
- Medibank Private's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Medibank Private's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Insurance industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Medibank Private has a total score of 3/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
MPL Health
How is Medibank Private's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Medibank Private's finances.
The net worth of a company is the difference between its assets and liabilities.
- Medibank Private is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Medibank Private's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- Low level of unsold assets.
- Medibank Private has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Medibank Private Company Filings, last reported 6 months ago.
| Date (Data in AUD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-31 | 1,838.80 | 0.00 | 2,401.30 |
| 2018-09-30 | 1,838.80 | 0.00 | 2,401.30 |
| 2018-06-30 | 1,829.20 | 0.00 | 2,746.60 |
| 2018-03-31 | 1,829.20 | 0.00 | 2,746.60 |
| 2017-12-31 | 1,778.90 | 0.00 | 2,453.90 |
| 2017-09-30 | 1,778.90 | 0.00 | 2,453.90 |
| 2017-06-30 | 1,719.80 | 0.00 | 2,632.70 |
| 2017-03-31 | 1,719.80 | 0.00 | 2,632.70 |
| 2016-12-31 | 1,643.60 | 0.00 | 2,264.80 |
| 2016-09-30 | 1,643.60 | 0.00 | 2,264.80 |
| 2016-06-30 | 1,578.70 | 0.00 | 2,454.50 |
| 2016-03-31 | 1,578.70 | 0.00 | 2,454.50 |
| 2015-12-31 | 1,525.70 | 0.00 | 2,158.40 |
| 2015-09-30 | 1,525.70 | 0.00 | 2,158.40 |
| 2015-06-30 | 1,442.00 | 0.00 | 2,380.20 |
| 2015-03-31 | 1,442.00 | 0.00 | 2,380.20 |
| 2014-12-31 | 1,298.90 | 0.00 | 1,896.00 |
| 2014-09-30 | 1,298.90 | 0.00 | 1,896.00 |
| 2014-06-30 | 1,393.90 | 0.00 | 2,198.00 |
| 2013-06-30 | 1,402.70 | 0.00 | 2,336.62 |
- Medibank Private has no debt.
- Medibank Private has not taken on any debt in the past 5 years.
- Medibank Private has no debt, it does not need to be covered by operating cash flow.
- Medibank Private has no debt, therefore coverage of interest payments is not a concern.
Financial health checks
We assess Medibank Private's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Medibank Private has a total score of 6/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
MPL Dividends
What is Medibank Private's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
A$2,000 of
Medibank Private
shares you are expected to receive
A$72
in your first year as a dividend.
Dividend Amount
- Medibank Private's pays a higher dividend yield than the bottom 25% of dividend payers in Australia (2.5%).
- Medibank Private's dividend is below the markets top 25% of dividend payers in Australia (5.77%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 10 Analyst Estimates (S&P Global) | See Below |
| Australia Insurance Industry Average Dividend Yield | Market Cap Weighted Average of 9 Stocks | 4.1% |
| Australia Market Average Dividend Yield | Market Cap Weighted Average of 416 Stocks | 4% |
| Australia Minimum Threshold Dividend Yield | 10th Percentile | 1.5% |
| Australia Bottom 25% Dividend Yield | 25th Percentile | 2.5% |
| Australia Top 25% Dividend Yield | 75th Percentile | 5.8% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in A$) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2023-06-30 | ||
| 2022-06-30 | ||
| 2021-06-30 | 0.12 | 9.00 |
| 2020-06-30 | 0.13 | 11.00 |
| 2019-06-30 | 0.13 | 11.00 |
| Date (Data in A$) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2019-02-14 | 0.129 | 4.303 |
| 2018-08-23 | 0.127 | 4.713 |
| 2017-08-24 | 0.120 | 3.916 |
| 2017-02-16 | 0.113 | 4.001 |
| 2016-08-18 | 0.120 | 4.546 |
| 2016-02-18 | 0.100 | 3.373 |
| 2015-08-20 | 0.053 | 2.278 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Whilst dividend payments have been stable, Medibank Private has been paying a dividend for less than 10 years.
- Dividend payments have increased, but Medibank Private only paid a dividend in the past 4 years.
Income/ dividend checks
We assess Medibank Private's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 1.5%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Medibank Private afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Medibank Private has a total score of 3/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
MPL Management
CEO
| COMPENSATION | A$3,672,652 |
| AGE | 58 |
| TENURE AS CEO | 3 years |
CEO Bio
Mr. Craig M. Drummond, BCom, CA, SF Fin, has been the Chief Executive Officer at Medibank Private Limited since July 4, 2016 and served as its Managing Director since July 4, 2016. Mr. Drummond served as the Chief Financial Officer of National Australia Bank Limited (NAB) until March 14, 2016 and also served as its Group Executive of Finance & Strategy from its joining in October 23, 2013 to March 15, 2016. He focused on further strengthening the Group's capital, funding and liquidity positions. He also oversaw the development of strategies to ensure the business was best placed to respond to future challenges and opportunities. He served as an Equity Analyst at Goldman Sachs JBWere Pty Ltd, Research Division. He served as the Chief Executive Officer and Country Head of Bank of America Merrill Lynch since October 2009. He served as the Head of Australian operations of Merrill Lynch & Co., Inc. since October 2009. He served as the Chief Executive Officer of Goldman Sachs Australia Pty. Ltd., since February 2007 and served as its Managing Director and Chief Operating Officer. He joined Goldman Sachs JB Were in 1986 in equity research and was in various roles as Chief Operating Officer, Chief Executive Officer and Executive Chairman from 2003 to May 2009. He served as the Chief Executive Officer and Chief Operating Officer at Goldman Sachs JBWere Pty Ltd. since February 2007 and served as its Co-Chief Executive Officer and Managing Director. He served as a Co-Head of Goldman Sachs JBWere Pty until September 2009. He served as an Equity Analyst at Goldman Sachs Group Inc., Research Division. He served as the Chairman of Goldman Sachs JBWere Pty Ltd. He has been a Director of Medibank Private Limited since July 4, 2016. He serves as a Director of Australian Financial Markets Association Limited. He serves as a Board Member of the Geelong Football Club Limited, the Florey Institute of Neuroscience & Mental Health. He served as a Director of Goldman Sachs Australia Pty. Ltd. Mr. Drummond graduated with a Bachelor of Commerce degree from The University of Melbourne in 1981. He completed the Advanced Management Program at Wharton University in 2001. He is a Senior Fellow of FINSIA and a Chartered Accountant.
CEO Compensation
- Craig's compensation has increased by more than 20% in the past year whilst earnings fell less than 20%.
- Craig's remuneration is about average for companies of similar size in Australia.
Management Team Tenure
Average tenure of the Medibank Private management team in years:
- The tenure for the Medibank Private management team is about average.
Management Team
Craig Drummond
CEO & Director
A$4M
58
3 yrs
Mark Rogers
Chief Financial Officer
A$1M
2.5 yrs
John Goodall
Group Executive of Technology & Operations
A$872K
2.6 yrs
Mei Ramsay
Group Executive of Legal
A$898K
2.8 yrs
Kylie Bishop
Group Executive of People & Culture
A$1M
6 yrs
David Koczkar
Group Chief Customer Officer
A$2M
2.8 yrs
Tom Exton
Group Financial Controller
Andrew Wilson
Group Executive of Healthcare & Strategy
A$2M
9 yrs
Emily Ritchie
Head of Media & External Affairs
Andrew Matthews
Chief Actuary
6.3 yrs
Board of Directors Tenure
Average tenure and age of the Medibank Private board of directors in years:
- The tenure for the Medibank Private board of directors is about average.
Board of Directors
Elizabeth Alexander
Chairman of the Board
A$425K
76
6.3 yrs
Craig Drummond
CEO & Director
A$4M
58
3 yrs
Peter Hodgett
Independent Non-Executive Director
A$210K
6.1 yrs
Linda Nicholls
Independent Non-Executive Director
A$193K
71
5.3 yrs
David Fagan
Independent Non-Executive Director
A$220K
5.3 yrs
Christine O’Reilly
Independent Non-Executive Director
A$210K
58
5.3 yrs
Anna Bligh
Independent Non-Executive Director
A$192K
6.6 yrs
Mike Wilkins
Independent Non-Executive Director
A$191K
62
2.2 yrs
Tracey Batten
Independent Non-Executive Director
A$153K
1.9 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (A$) | Value (A$) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 28. Feb 19 | Buy | Tracey Batten | Individual | 26. Feb 19 | 26. Feb 19 | 14,285 | A$2.78 | A$39,712 | ||
| 21. Feb 19 | Buy | Michael Wilkins | Individual | 19. Feb 19 | 19. Feb 19 | 25,513 | A$2.93 | A$74,654 | ||
| 06. Feb 19 | Buy | Schroder Investment Management Limited | Company | 06. Oct 18 | 06. Feb 19 | 40,598,812 | A$2.57 | A$104,300,356 | ||
| 19. Nov 18 | Sell | The Vanguard Group, Inc. | Company | 18. Jul 18 | 15. Nov 18 | -1,168,918 | A$3.26 | A$-3,775,610 | ||
| 19. Nov 18 | Buy | The Vanguard Group, Inc. | Company | 16. Jul 18 | 15. Nov 18 | 5,573,613 | A$3.30 | A$18,312,542 | ||
| 22. Nov 18 | Sell | Perpetual Limited | Company | 04. Jun 18 | 07. Nov 18 | -25,158,828 | A$3.12 | A$-78,611,091 | ||
| 22. Nov 18 | Buy | Perpetual Limited | Company | 14. May 18 | 21. Nov 18 | 53,766,707 | A$2.86 | A$153,636,137 | ||
| 06. Sep 18 | Buy | Tracey Batten | Individual | 04. Sep 18 | 04. Sep 18 | 10,000 | A$3.02 | A$30,200 | ||
Management checks
We assess Medibank Private's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Medibank Private has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
MPL News
Simply Wall St News
Who Has Been Buying Medibank Private Limited (ASX:MPL) Shares?
So we'll take a look at whether insiders have been buying or selling shares in Medibank Private Limited (ASX:MPL). … For example, a Harvard University study found that 'insider purchases earn abnormal returns of more than 6% per year.' See our latest analysis for Medibank Private The Last 12 Months Of Insider Transactions At Medibank Private Independent Non-Executive Director Michael Wilkins made the biggest insider purchase in the last 12 months. … Our data indicates that Medibank Private insiders own about AU$7.6m worth of shares (which is 0.08% of the company).
Simply Wall St - – Full articleHow Many Medibank Private Limited (ASX:MPL) Shares Do Institutions Own?
The big shareholder groups in Medibank Private Limited (ASX:MPL) have power over the company. … See our latest analysis for Medibank Private ASX:MPL Ownership Summary, June 26th 2019 What Does The Institutional Ownership Tell Us About Medibank Private? … General Public Ownership The general public -- mostly retail investors -- own 64% of Medibank Private.
Simply Wall St - – Full articleWhat Did Medibank Private Limited's (ASX:MPL) CEO Take Home Last Year?
Craig Drummond has been the CEO of Medibank Private Limited (ASX:MPL) since 2016. … Our data indicates that Medibank Private Limited is worth AU$8.8b, and total annual CEO compensation is AU$3.7m. … If you think CEO compensation levels are interesting you will probably really like this free visualization of insider trading at Medibank Private.
Simply Wall St - – Full articleShould You Buy Medibank Private Limited (ASX:MPL) For Its Dividend?
Could Medibank Private Limited (ASX:MPL) be an attractive dividend share to own for the long haul? … On the other hand, investors have been known to buy a stock because of its yield, and then lose money if the company's dividend doesn't live up to expectations. … With a goodly-sized dividend yield despite a relatively short payment history, investors might be wondering if Medibank Private is a new dividend aristocrat in the making.
Simply Wall St - – Full articleShould You Be Impressed By Medibank Private Limited's (ASX:MPL) ROE?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. … Another way to think of that is that for every A$1 worth of equity in the company, it was able to earn A$0.22. … Return on Equity = Net Profit ÷ Shareholders' Equity
Simply Wall St - – Full articleWhat Kind Of Shareholders Own Medibank Private Limited (ASX:MPL)?
Generally speaking, as a company grows, institutions will increase their ownership. … Medibank Private is a pretty big company. … Our analysis of the ownership of the company, below, shows that.
Simply Wall St - – Full articleHave Insiders Been Buying Medibank Private Limited (ASX:MPL) Shares?
We often see insiders buying up shares in companies that perform well over the long term. … So shareholders might well want to know whether insiders have been buying or selling shares in Medibank Private Limited (ASX:MPL). … The Last 12 Months Of Insider Transactions At Medibank Private.
Simply Wall St - – Full articleMedibank Private Limited (ASX:MPL) Investors Are Paying Above The Intrinsic Value
Valuing MPL, an insurance stock, can be daunting since these financial firms generally have cash flows that are impacted by regulations that are not imposed upon other industries. … For example, insurance companies are required to hold more capital to reduce the risk to shareholders.
Simply Wall St - – Full articleHow Much is Medibank Private Limited's (ASX:MPL) CEO Getting Paid?
Craig Drummond has been the CEO of Medibank Private Limited (ASX:MPL) since 2016. … This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. … How Does Craig Drummond's Compensation Compare With Similar Sized Companies?
Simply Wall St - – Full articleShould You Buy Medibank Private Limited (ASX:MPL) For Its Dividend?
A sizeable part of portfolio returns can be produced by dividend stocks due to their contribution to compounding returns in the long run. … In the last few years Medibank Private Limited (ASX:MPL) has paid a dividend to shareholders. … Let's dig deeper into whether Medibank Private should have a place in your portfolio.
Simply Wall St - – Full articleMPL Company Info
Description
Medibank Private Limited, an integrated healthcare company, provides private health insurance and health solutions in Australia. It operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment offers private health insurance products, including hospital cover that provides members with health cover for hospital treatments; and ancillary cover, which offers members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also provides health insurance products to overseas visitors and overseas students. The Medibank Health segment offers health management and telehealth services to government and corporate customers, as well as distributes travel, life, and pet insurance products. The company underwrites its health insurance products under the Medibank and ahm brands. Medibank Private Limited was founded in 1976 and is based in Docklands, Australia.
Details
| Name: | Medibank Private Limited |
| MPL | |
| Exchange: | ASX |
| Founded: | 1976 |
| A$9,859,331,599 | |
| 2,754,003,240 | |
| Website: | http://www.medibank.com.au |
| Address: |
Medibank Private Limited 720 Bourke Street, Docklands, Victoria, 3008, Australia |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| ASX | MPL | Ordinary Shares | Australian Securities Exchange | AU | AUD | 25. Nov 2014 | |
| OTCPK | MDBP.F | Ordinary Shares | Pink Sheets LLC | US | USD | 25. Nov 2014 | |
| DB | MPV | Ordinary Shares | Deutsche Boerse AG | DE | EUR | 25. Nov 2014 | |
| CHIA | MPL | Ordinary Shares | Chi-X Australia | AU | AUD | 25. Nov 2014 |
Number of employees
Current staff
Industry
| Life and Health Insurance | |
| Insurance |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/07/16 11:53 |
| End of day share price update: | 2019/07/15 00:00 |
| Last estimates confirmation: | 2019/07/15 |
| Last earnings filing: | 2019/02/14 |
| Last earnings reported: | 2018/12/31 |
| Last annual earnings reported: | 2018/06/30 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
